Developing a kinase inhibitor drug to treat spinal cord injury

NARRATIVE Axons (the long cellular connections among nerve cells) typically fail to regrow when severed, leading to paralysis after spinal cord injury. We have discovered a series of compounds that promote the growth of axons in the brain and spinal cord. The goal of this proposal is to improve the properties of these compounds to generate candidate drugs that can be tested in clinical trials of injured patients.